Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics
An Open, Mono-Centre Trial to Investigate the Correlation Between Concentrations of Glucose in Arterialized Venous Blood and Subcutaneous Interstitial Fluid Applying Different Extracorporeal Sensor Techniques in Type 1 Diabetics
1 other identifier
observational
16
1 country
1
Brief Summary
This is a mono-centre trial performed at the Center for Clinical Research at the Medical University Graz. There will be a screening information and a study visit.In the study visit arterialized venous blood glucose values will be monitored and subcutaneous sampling of interstitial fluid (ISF) with microdialysis for glucose determination will be performed. Additionally to the laboratory analysis of the subcutaneous glucose samples, the glucose will be measured with extracorporeal on-line sensors and two marketed devices (Guardian RT and Glucoday S).The study visit will last 30 hours starting with the insertion of microdialysis catheters in the abdominal subcutaneous tissue and the insertion of the catheters for the Glucoday S system and Guardian RT system. The primary hypothesis of the study is: Interstitial fluid glucose concentration profiles correlate to the arterialized venous blood glucose concentration profile in type 1 diabetic subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 11, 2007
CompletedFirst Posted
Study publicly available on registry
July 12, 2007
CompletedJuly 12, 2007
April 1, 2006
July 11, 2007
July 11, 2007
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Signed informed consent obtained before any trial-related activities.
- Skin fold thickness of minimally 5 mm
- Age of patients in the range from 19 to 60 years.
- Type 1 diabetes
You may not qualify if:
- Severe acute and/or chronic diseases
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation.
- Taking of any vasoactive substances or anticoagulation medication.
- Diseases of the skin which could interfere with application of the catheters
- Pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University Graz - Clinical Research Center
Graz, Styria, 8010, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas R Pieber, MD
Medical University Graz, Graz, Austria
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 11, 2007
First Posted
July 12, 2007
Study Start
February 1, 2006
Last Updated
July 12, 2007
Record last verified: 2006-04